| Sergey Cherneykin, MD | |
|
55 Palmer Ave, Bronxville, NY 10708-3403 | |
| (914) 787-3265 | |
| Not Available |
| Full Name | Sergey Cherneykin |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 35 Years |
| Location | 55 Palmer Ave, Bronxville, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568674828 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 256571 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York-presbyterian Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trustees Of Columbia University In The City Of New York | 8527972546 | 1895 |
News Archive
Insects and plants have an important ancient defense mechanism that helps them to fight viruses. This is encoded in their DNA. Scientists have long assumed that vertebrates - including humans - also had this same mechanism. But researchers at KU Leuven, Belgium, have found that vertebrates lost this particular asset in the course of their evolution.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
The science of pharmacogenomics (PGx) studies how genetic variability affects an individual's response to a drug. Most patients metabolize a medication as expected. But some eliminate it from the body before it can do its work, while others process it slowly, causing it to build up in the body and risk an overdose.
Doctors can use either an artery in the arm or in the groin to safely perform percutaneous coronary intervention on patients presenting with a heart attack, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Boston Scientific Europe announced the launch of the RESONATE™ cardiac resynchronisation therapy defibrillator (CRT-D) systems in Europe, a new family of devices featuring SmartCRT technology, which recently received CE Mark and are now available for heart failure patients across Europe.
› Verified 1 days ago
| Entity Name | Gastroenterology And Liver Associates Of Riverdale Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023272846 PECOS PAC ID: 1456529098 Enrollment ID: O20110726000193 |
News Archive
Insects and plants have an important ancient defense mechanism that helps them to fight viruses. This is encoded in their DNA. Scientists have long assumed that vertebrates - including humans - also had this same mechanism. But researchers at KU Leuven, Belgium, have found that vertebrates lost this particular asset in the course of their evolution.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
The science of pharmacogenomics (PGx) studies how genetic variability affects an individual's response to a drug. Most patients metabolize a medication as expected. But some eliminate it from the body before it can do its work, while others process it slowly, causing it to build up in the body and risk an overdose.
Doctors can use either an artery in the arm or in the groin to safely perform percutaneous coronary intervention on patients presenting with a heart attack, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Boston Scientific Europe announced the launch of the RESONATE™ cardiac resynchronisation therapy defibrillator (CRT-D) systems in Europe, a new family of devices featuring SmartCRT technology, which recently received CE Mark and are now available for heart failure patients across Europe.
› Verified 1 days ago
| Entity Name | Trustees Of Columbia University In The City Of New York |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508266347 PECOS PAC ID: 8527972546 Enrollment ID: O20151201002613 |
News Archive
Insects and plants have an important ancient defense mechanism that helps them to fight viruses. This is encoded in their DNA. Scientists have long assumed that vertebrates - including humans - also had this same mechanism. But researchers at KU Leuven, Belgium, have found that vertebrates lost this particular asset in the course of their evolution.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
The science of pharmacogenomics (PGx) studies how genetic variability affects an individual's response to a drug. Most patients metabolize a medication as expected. But some eliminate it from the body before it can do its work, while others process it slowly, causing it to build up in the body and risk an overdose.
Doctors can use either an artery in the arm or in the groin to safely perform percutaneous coronary intervention on patients presenting with a heart attack, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Boston Scientific Europe announced the launch of the RESONATE™ cardiac resynchronisation therapy defibrillator (CRT-D) systems in Europe, a new family of devices featuring SmartCRT technology, which recently received CE Mark and are now available for heart failure patients across Europe.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sergey Cherneykin, MD 17 Kraft Ave, Bronxville, NY 10708-4103 Ph: (914) 771-6629 | Sergey Cherneykin, MD 55 Palmer Ave, Bronxville, NY 10708-3403 Ph: (914) 787-3265 |
News Archive
Insects and plants have an important ancient defense mechanism that helps them to fight viruses. This is encoded in their DNA. Scientists have long assumed that vertebrates - including humans - also had this same mechanism. But researchers at KU Leuven, Belgium, have found that vertebrates lost this particular asset in the course of their evolution.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
The science of pharmacogenomics (PGx) studies how genetic variability affects an individual's response to a drug. Most patients metabolize a medication as expected. But some eliminate it from the body before it can do its work, while others process it slowly, causing it to build up in the body and risk an overdose.
Doctors can use either an artery in the arm or in the groin to safely perform percutaneous coronary intervention on patients presenting with a heart attack, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Boston Scientific Europe announced the launch of the RESONATE™ cardiac resynchronisation therapy defibrillator (CRT-D) systems in Europe, a new family of devices featuring SmartCRT technology, which recently received CE Mark and are now available for heart failure patients across Europe.
› Verified 1 days ago
Dr. Jose E Maccera, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 55 Palmer Rd, Lawrence Hospital Center, Bronxville, NY 10708 Phone: 914-787-3265 Fax: 914-787-3269 |